首站-论文投稿智能助手
典型文献
A prospective randomized controlled study on scheduled PDE5i and vacuum erectile devices in the treatment of erectile dysfunction after nerve sparing prostatectomy
文献摘要:
Cavernous nerve injury is an important cause of erectile dysfunction(ED).Although protective nerve technology has been widely used in nerve-sparing radical prostatectomy(nsRP),the incidence of ED is still very high after surgery.The purpose of our study was to evaluate erectile function(EF)and penile length in the non-erectile state(PLNES)following scheduled phosphodiesterase 5 inhibitor(PDE5i),vacuum erectile device(VED)treatment,and combination therapy after nsRP.One hundred patients with localized prostate cancer and normal EF were randomized to scheduled PDE5i group,VED treatment group,a combined treatment group,and the control group without any intervention.The International Index of Erectile Function-5(IIEF-5)scores and PLNES were evaluated after 6 months and 12 months of treatment.Sexual Encounter Profile(SEP-Question 2 and SEP-Question 3)were evaluated after 12 months of treatment.Ninety-one of the 100 randomized patients completed the study.We found that the 5 mg tadalafil once a day(OaD)combined with VED can help improve IIEF-5 scores in nsRP patients after both 6 months and 12 months.VED alone or combined with tadalafil OaD can help patients maintain PLNES.VED combined with tadalafil OaD can improve the rate of successful penetration(SEP-Question 2)after 12 months.There were no significant differences in the return to target EF after 12 months among the groups.No significant correlation was noted between the variables and return to target EF(IIEF≥17),and between the variables and effective shortening of the patient's penis(shortening≥1 cm)after 12 months of intervention.
文献关键词:
作者姓名:
Ming Zhang;Ji-Zhong Che;Yi-Dong Liu;Hong-Xiang Wang;Yan-Ping Huang;Xiang-Guo Lv;Wei Liu;Mu-Jun Lu
作者机构:
Department of Urology and Andrology,Shanghai Institute of Andrology,Renji Hospital,Shanghai Jiao Tong University School of Medicine,Shanghai 200001,China;Department of Urology,Yantai Affiliated Hospital of Binzhou Medical University,Yantai 264100,China
引用格式:
[1]Ming Zhang;Ji-Zhong Che;Yi-Dong Liu;Hong-Xiang Wang;Yan-Ping Huang;Xiang-Guo Lv;Wei Liu;Mu-Jun Lu-.A prospective randomized controlled study on scheduled PDE5i and vacuum erectile devices in the treatment of erectile dysfunction after nerve sparing prostatectomy)[J].亚洲男性学杂志(英文版),2022(05):473-477
A类:
nsRP,penile,PLNES,Encounter,tadalafil,OaD
B类:
prospective,randomized,controlled,study,scheduled,PDE5i,vacuum,erectile,devices,treatment,dysfunction,after,nerve,sparing,prostatectomy,Cavernous,injury,important,cause,Although,protective,technology,has,been,widely,used,radical,incidence,still,very,high,surgery,purpose,our,was,length,following,phosphodiesterase,inhibitor,VED,combination,therapy,One,hundred,patients,localized,cancer,normal,were,combined,without,any,intervention,International,Index,Erectile,Function,IIEF,scores,evaluated,months,Sexual,Profile,SEP,Question,Ninety,completed,We,found,that,once,day,help,improve,both,alone,maintain,rate,successful,penetration,There,significant,differences,return,target,among,groups,No,correlation,noted,between,variables,effective,shortening,penis
AB值:
0.390274
相似文献
Comparison of outcomes between immediate implant- based and autologous reconstruction: 15-year, single-center experience in a propensity score-matched Chinese cohort
Shanshan He;Bowen Ding;Gang Li;Yubei Huang;Chunyong Han;Jingyan Sun;Qingfeng Huang;Jing Liu;Zhuming Yin;Shu Wang;Jian Yin-Department of Breast Reconstruction,Key Laboratory of Breast Cancer Prevention and Therapy,Tianjin Medical University,Ministry of Education,Sino-Russian Joint Research Center for Oncoplastic Breast Surgery,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China;School of Pharmacy,University College London,London WC1N 1AX,UK;Department of Cancer Epidemiology and Biostatistics,Tianjin Medical University Cancer Institute&Hospital,National Clinical Research Center for Cancer,Key Laboratory of Cancer Prevention and Therapy,Tianjin,Tianjin's Clinical Research Center for Cancer,Tianjin 300060,China
Using a consensus acupoints regimen to explore the relationship between acupuncture sensation and lumbar spinal postoperative analgesia:A retrospective analysis of prospective clinical cooperation
Yen-Lin Chao;Yi-Ai Rau;Hong-Sheng Shiue;Jiun-Lin Yan;Yuan-Yun Tang;Shao-Wen Yu;Bo-Yan Yeh;Yen-Lung Chen;Tsung-Hsien Yang;Shu-Chen Cheng;Yi-Wen Hsieh;Hsin-Chia Huang;Fu-Kuang Tsai;Yu-Sheng Chen;Geng-Hao Liu-Division of Acupuncture and Moxibustion,Department of Traditional Chinese Medicine,Chang Gung Memorial Hospital,Taoyuan 333,Taiwan,China;School of Traditional Chinese Medicine,College of Medicine,Chang Gung University,Taoyuan 333,Taiwan,China;Department of Neurosurgery,Keelung Chang Gung Memorial Hospital,Keelung 204,Taiwan,China;Department of Traditional Chinese Medicine,New Taipei Municipal TuCheng Hospital,Chang Gung Memorial Hospital,New Taipei 236,Taiwan,China;Sleep Center,Chang Gung Memorial Hospital,Taoyuan 333,Taiwan,China
Dynamic changes of renal cortical blood perfusion before and after percutaneous transluminal renal artery stenting in patients with severe atherosclerotic renal artery stenosis
Ma Na;Li Yan;Wang Siyu;Li Mengpu;Li Yongjun;Ai Hu;Zhu Hui;Wang Yang;Guo Fajin;Ren Junhong-Department of Sonography, Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Vascular Surgery, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Cardiology, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Nuclear Medicine, National Center of Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Science, Beijing 100730, China;Department of Medical Research & Biometrics Center, National Center for Cardiovascular Diseases and Fuwai Hospital, CAMS and PUMC, Beijing 100037, China
Wenshen Jianpi recipe(温肾健脾方)induced immune reconstruction and redistribution of natural killer cell subsets in immunological non-responders of human immunodeficiency virus/acquired immune deficiency syndrome:a randomized controlled trial
TAO Zhuang;WANG Jian;CHEN Xin;LI Yonghong;YAN Yuguang;ZHANG Ao;ZOU Wen;LIU Ying-Research Center of AIDS Treatment with Traditional Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Institute of Basic Theory for Chinese Medicine,China Academy of Chinese Medical Sciences,Beijing 100700,China;Department of Integrated Traditional Chinese and Wetern Medicine,Kunming Hospital of Traditional Chinese Medicine,Kunming 650000,China;Department of Infection,No.6 People's Hospital of Shenyang City,Shenyang 110006,China;University of Chinese Academy of SoCIal SCIences,Beijing,100102,China
Effect of treatment with Fufang Huangqi decoction(复方黄杞汤剂)on dose reductions and discontinuation of pyridostigmine bromide tablets,prednisone,and tacrolimus in patients with type Ⅰ or Ⅱ myasthenia gravis
SHAN Caifeng;ZHANG Jingsheng;LIN Yi;HUANG Xueshi;WANG Zhanyou;PAN Haiou;QIAO Wenjun-the Affiliated Hospital of Liaoning University of Traditional Chinese Medicine,Liaoning Provincial Key Laboratory for Diagnosis and Treatment of Myasthenia Gravis,Liaoning University of Traditional Chinese Medicine,Shenyang 110033,China;Department of General Surgery,the First People's Hospital of Shenyang,Shenyang 110091,China;Institute of Microbial Pharmaceuticals,College of Life and Health Sciences,Northeastern University,Shenyang 110819,China;Institute of Health Sciences,Key Laboratory of Medical Cell Biology of Ministry of Education,China Medical University,Shenyang 110122,China;Liaoning University of Traditional Chinese Medicine,foreign language college,Liaoning University of Traditional Chinese Medicine,Shenyang 110033,China
Clinical value of next-generation sequencing in guiding decisions regarding endocrine therapy for advanced HR-positive/HER-2-negative breast cancer
Dan Lyu;Binliang Liu;Bo Lan;Xiaoying Sun;Lixi Li;Jingtong Zhai;Haili Qian;Fei Ma-Department of Medical Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Department of Breast Cancer Medical Oncology,Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine,Central South University,Changsha 410013,China;Department of Medical Oncology,Cancer Hospital of Huanxing Chaoyang District,Beijing 100122,China;State Key Laboratory of Molecular Oncology,National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
Clinical outcomes of atezolizumab in combination with etoposide/platinum for treatment of extensive-stage small-cell lung cancer:A real-world,multicenter,retrospective,controlled study in China
Hanxiao Chen;Xiangjuan Ma;Jie Liu;Yu Yang;Yong Fang;Liping Wang;Jian Fang;Jun Zhao;Minglei Zhuo-Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department Ⅰ of Thoracic Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department Ⅱ of Thoracic Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Pneumology,Shandong Cancer Hospital and Institute,Shandong First Medical University and Shandong Academy of Medical Sciences,Jinan 250117,China;Department of Oncology,the 2nd Affiliated Hospital of Harbin Medical University,Harbin 150001,China;Department of Oncology,Sir Run Run Shaw Hospital Zhejiang University School of Medicine,Hangzhou 310020,China;Department of Oncology,Baotou Cancer Hospital,Baotou 014030,China
Adjuvant tamoxifen switched to exemestane treatment in postmenopausal women with estrogen receptor-positive early breast cancer: A pragmatic, multicenter, and prospective clinical trial in China
Binghe Xu;Huiping Li;Zefei Jiang;Lin Gu;Jinhai Tang;Hui Xie;Yueyin Pan;Yunjiang Liu;Shude Cui;Xiaojia Wang;Li Cai;Yiqiong Zhang;Huadong Zhao;Zhimin Shao-Department of Medical Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China;Key Laboratory of Carcinogenesis and Translational Research(Ministry of Education/Beijing),Department of Breast Oncology,Peking University Cancer Hospital&Institute,Beijing 100142,China;Department of Breast Cancer,the Fifth Medical Center of Chinese PLA General Hospital,Beijing 100071,China;Department of Breast Cancer,Tianjin Cancer Institute and Hospital,Tianjin 300060,China;Department of Breast Cancer,Jiangsu Provincial Hospital,Nanjing 210029,China;Department of Breast Cancer,the First Affiliated Hospital of China University of Science and Technology,Hefei 230001,China;Department of Breast Cancer,the Fourth Hospital of Hebei Medical University,Shijiazhuang 050011,China;Department of Breast Cancer,Henan Cancer Hospital,Zhengzhou 450008,China;Department of Breast Cancer,Zhejiang Cancer Hospital,Hangzhou 310012,China;Department of Breast Cancer,Harbin Medical University Cancer Hospital,Harbin 150081,China;Department of Clinical Development,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Statistics,Pfizer(China)R&D Co.Ltd,Shanghai 201203,China;Department of Breast Surgery,Shanghai Cancer Center/Cancer Institute,Shanghai Medical College,Fudan University,Shanghai 200032,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。